Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trial

R Morriss, PM Briley, L Webster, M Abdelghani… - Nature Medicine, 2024 - nature.com
Disruption in reciprocal connectivity between the right anterior insula and the left
dorsolateral prefrontal cortex is associated with depression and may be a target for …

Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective

A Etkin, J Powell, AJ Savitz - Neuropsychopharmacology, 2024 - nature.com
Neuroimaging, across positron emission tomography (PET), electroencephalography (EEG),
and magnetic resonance imaging (MRI), has been a mainstay of clinical neuroscience …

Bringing Imaging Biomarkers Into Clinical Reality in Psychiatry

A Etkin, DH Mathalon - JAMA psychiatry, 2024 - jamanetwork.com
Importance Advancing precision psychiatry, where treatments are based on an individual's
biology rather than solely their clinical presentation, requires attention to several key …

A qualitative exploration of participant experiences of using Alpha-Stim AID for the treatment of moderate severity depressive symptoms in primary care

P Patel, C Boutry, A Dalby, D Butler, F Higton… - Psychiatry Research …, 2023 - Elsevier
Abstract Background Alpha-Stim AID is a device for the treatment of anxiety, insomnia and
depression. Evidence on patient experiences of using the device for depressive symptoms is …

Brain connectivity-guided, Optimised theta burst transcranial magnetic stimulation to improve Central Pain Modulation in knee Osteoarthritis Pain (BoostCPM) …

M Drabek, D Hodkinson, S Horvath, B Millar… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Chronic pain is a common health problem that is not efficiently managed by
standard analgesic treatments. There is evidence that treatment resistance may result from …

[HTML][HTML] Connectivity-guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe …

S Pszczolkowski, WJ Cottam, PM Briley… - JMIR Research …, 2022 - researchprotocols.org
Background Depression is a substantial health and economic burden. In approximately one-
third of patients, depression is resistant to first-line treatment; therefore, it is essential to find …

Effect and neural mechanisms of the transcutaneous vagus nerve stimulation for relapse prevention in patients with remitted major depressive disorder: protocol for a …

ZQ Zhang, ZP Guo, XY Lv, P Sörös, XX Wang… - BMJ open, 2022 - bmjopen.bmj.com
Introduction After the first episode, patients with remitted major depressive disorder (MDD)
have a 60% chance of experiencing a second episode. There are currently no accepted …

[HTML][HTML] Protocol: Effect and neural mechanisms of the transcutaneous vagus nerve stimulation for relapse prevention in patients with remitted major depressive …

ZQ Zhang, ZP Guo, XY Lv, P Sörös, XX Wang, L Wang… - BMJ Open, 2022 - ncbi.nlm.nih.gov
Introduction After the first episode, patients with remitted major depressive disorder (MDD)
have a 60% chance of experiencing a second episode. There are currently no accepted …

BRIGhTMIND trial-motivating mechanism of action analysis plan: Magnetic Resonance Spectroscopy

H Oh - 2023 - rdmc.nottingham.ac.uk
This is the acquired spectra processing and statistical analysis plans for the BRIGhTMIND
clinical trial. It demonstrates hypotheses related with magnetic resonance spectroscopy …

[引用][C] BRIGhTMIND baseline imaging statistical plan: theme 1-treatment resistant depression

W Cottam, P Briley, S Barber, A Suazo Di Paola… - 2021 - rdmc.nottingham.ac.uk
BRIGhTMIND baseline imaging statistical plan: theme 1 - treatment resistant depression
University of Nottingham logo, linking to repository homepage Toggle navigation View Item …